Is there a future for additive manufactured titanium bioglass composites in biomedical application? A perspective

Biointerphases. 2020 Dec 10;15(6):068501. doi: 10.1116/6.0000557.

Abstract

Additive manufacturing (AM) of orthopedic implants is growing in popularity as it offers almost complete design flexibility and freedom, meaning complex geometries mimicking specific body parts can be easily produced. Novel composite materials with optimized functionalities present opportunities for 3D printing osteoconductive implants with desirable mechanical properties. Standard metals for bone implants, such as titanium and its alloys, are durable and nontoxic but lack bioactivity. Bioactive glasses promote strong bone formation but are susceptible to brittle failure. Metal-bioactive glass composites, however, may combine the mechanical reliability of metals with the bone-bonding ability of bioactive glasses, potentially reducing the incidence of implant failure. Processing such composites by AM paves the way for producing unprecedented bespoke parts with highly porous lattices, whose stiffness can be tailored to meet the mechanical properties of natural bone tissue. This Perspective focuses on titanium-bioactive glass composites, critically discussing their processability by AM and highlighting their potential as a next-generation implantable biomaterial.

MeSH terms

  • Alloys / chemistry
  • Alloys / metabolism
  • Biocompatible Materials / chemistry
  • Bone-Implant Interface
  • Ceramics / chemistry*
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Porosity
  • Surface Properties
  • Tissue Scaffolds / chemistry
  • Titanium / chemistry*

Substances

  • Alloys
  • Biocompatible Materials
  • Bioglass
  • titanium alloy (TiAl6V4)
  • Titanium